Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Current Deferred Revenue (2019 - 2025)

SRx Health Solutions (SRXH) has disclosed Current Deferred Revenue for 5 consecutive years, with $38000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Deferred Revenue changed N/A year-over-year to $38000.0, compared with a TTM value of $38000.0 through Jun 2025, changed N/A, and an annual FY2024 reading of $500000.0, changed N/A over the prior year.
  • Current Deferred Revenue was $38000.0 for Q2 2025 at SRx Health Solutions, down from $500000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $500000.0 in Q4 2024 and bottomed at $29000.0 in Q3 2024.
  • Average Current Deferred Revenue over 3 years is $264800.0, with a median of $257000.0 recorded in 2021.
  • Peak annual rise in Current Deferred Revenue hit 22.12% in 2021, while the deepest fall reached 22.12% in 2021.
  • Year by year, Current Deferred Revenue stood at $257000.0 in 2021, then soared by 94.55% to $500000.0 in 2024, then tumbled by 92.4% to $38000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for SRXH at $38000.0 in Q2 2025, $500000.0 in Q1 2025, and $500000.0 in Q4 2024.